Arch Biopartners Inc

NEW
OTCPK:ACHFF (Canada)  
$ 0.64 +0.032 (+5.3%) 10:08 PM EST
At Loss
Market Cap:
$ 45.44M
Enterprise V:
$ 46.94M
Volume:
22.00K
Avg Vol (2M):
32.26K
Trade In:
Volume:
22.00K
At Loss
Avg Vol (2M):
32.26K

Business Description

Description
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
Name Current Vs Industry Vs History
Cash-To-Debt
0.17
Equity-to-Asset
-7.87
Debt-to-Equity
-0.7
Debt-to-EBITDA
-1.1
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
-3.6
3-Year Book Growth Rate
6.4
Name Current Vs Industry Vs History
5-Day RSI
66.31
9-Day RSI
70
14-Day RSI
70.13
3-1 Month Momentum %
-18.38
6-1 Month Momentum %
-64.88
12-1 Month Momentum %
-77.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.11
Quick Ratio
0.11
Cash Ratio
0.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-2
Shareholder Yield %
-1.55
Name Current Vs Industry Vs History
ROA %
-919.8
ROIC %
-95.62
3-Year ROIIC %
-41.01
Moat Score
2
Tariff Resilience Score
6

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-28.57
EV-to-EBITDA
-28.57
EV-to-Forward-Revenue
51
EV-to-FCF
-60.49
Earnings Yield (Greenblatt) %
-3.5
FCF Yield %
-1.71

Financials

ACHFF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ACHFF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Arch Biopartners Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.037
Beta 2.3357
3-Year Sharpe Ratio -0.53
3-Year Sortino Ratio -0.71
Volatility % 58.04
14-Day RSI 70.13
14-Day ATR ($) 0.057392
20-Day SMA ($) 0.427563
12-1 Month Momentum % -77.09
52-Week Range ($) 0.2881 - 1.385
Shares Outstanding (Mil) 67.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arch Biopartners Inc Filings

Filing Date Document Date Form
No Filing Data

Arch Biopartners Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Arch Biopartners Inc Frequently Asked Questions

What is Arch Biopartners Inc(ACHFF)'s stock price today?
The current price of ACHFF is $0.64. The 52 week high of ACHFF is $1.39 and 52 week low is $0.29.
When is next earnings date of Arch Biopartners Inc(ACHFF)?
The next earnings date of Arch Biopartners Inc(ACHFF) is .
Does Arch Biopartners Inc(ACHFF) pay dividends? If so, how much?
Arch Biopartners Inc(ACHFF) does not pay dividend.

Guru Commentaries on OTCPK:ACHFF

No articles.

Press Release

Subject Date
No Press Release

Articles on Arch Biopartners Inc

No articles.